This inventor holds 2 USPTO granted patents, plus 1 CIPO patent. Top assignee: Laboratoire Francais Du Fractionnement Et Des Biotechnologies. Active years: 2017-2020.
Company Filing History:
Years Active: 2017-2020
Title: Paul Boulange: Innovator in Albumin Purification
Introduction
Paul Boulange is a notable inventor based in Orsay, France. He has made significant contributions to the field of biotechnology, particularly in the purification of albumin. With a total of 2 patents to his name, Boulange's work focuses on enhancing the safety and efficacy of therapeutic solutions.
Latest Patents
Boulange's latest patents include an innovative albumin-purification method that incorporates a nanofiltration step. This method involves subjecting an aqueous albumin solution, with a concentration ranging from 15 g/l to 80 g/l and a pH of not less than 7, to nanofiltration within a temperature range of 15°C to 55°C. The invention also encompasses a virally-safe aqueous albumin solution, which is produced using this method. This solution ensures that the sites for the transport and binding of active therapeutic ingredients remain available. Additionally, Boulange has developed an albumin composition for therapeutic use, which is derived from the adapted albumin solution intended for clinical applications.
Career Highlights
Paul Boulange is associated with Laboratoire Français du Fractionnement et des Biotechnologies, where he applies his expertise in biotechnology and patent development. His work has been instrumental in advancing methods for purifying albumin, which is crucial for various therapeutic applications.
Collaborations
Boulange collaborates with esteemed colleagues such as Stephane Boyer and Sami Chtourou. Their combined efforts contribute to the innovative research and development in the field of biotechnologies.
Conclusion
Paul Boulange stands out as a significant figure in the realm of albumin purification, with his innovative methods paving the way for safer therapeutic solutions. His contributions continue to impact the biotechnology industry positively.